This HTML5 document contains 55 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n8http://dx.doi.org/10.1182/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q72998755
rdf:type
wikibase:Item
schema:description
scientific article published on 13 February 2003 наукова стаття, опублікована в лютому 2003 im Februar 2003 veröffentlichter wissenschaftlicher Artikel article scientifique publié en 2003 artículu científicu espublizáu en febreru de 2003 wetenschappelijk artikel
p:P577
wds:Q72998755-8B9F4FE4-F8B4-45D8-911C-A67D9AB87D64
wdt:P577
2003-02-13T00:00:00Z
p:P2093
wds:Q72998755-FFD3D145-43C0-4D15-88E7-0A76828C22FD wds:Q72998755-07B1C2A9-B2E9-407B-ADC4-B30CB81FC6EF wds:Q72998755-28285438-6C9A-4432-A5AC-B9A25BE4206F wds:Q72998755-043CF171-2415-4198-B871-B7797CAB79C0 wds:Q72998755-5C99603C-4C74-4F28-9BD5-9DE8178297F3 wds:Q72998755-3941B643-F569-4BB1-9219-36B96F3A2793
wdt:P2093
Zhen Fan Yasodha Natkunam Sheila Breslin Sandra J Horning Jennifer B Lucas Bradley C Ekstrand
rdfs:label
Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial
skos:prefLabel
Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial
schema:name
Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial
p:P50
wds:Q72998755-92783341-84A0-4BDE-8B0C-5BC417809406 wds:Q72998755-B604307C-BB88-4406-887F-1F48597D4EA0 wds:Q72998755-59E1024C-F449-4658-970F-17F35CF3DA13
wdt:P50
wd:Q85620133 wd:Q91183516 wd:Q60545128
p:P1476
wds:Q72998755-B7F4DE1E-6766-4970-995F-F5AAF0887D98
wdt:P1476
Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial
p:P304
wds:Q72998755-C82809FD-99B1-4EC4-9125-7BF5DAB9D4E6
wdt:P304
4285-4289
p:P31
wds:Q72998755-33285FDE-5F89-441A-8863-E804BC4526AB
wdt:P31
wd:Q13442814
p:P921
wds:Q72998755-39360727-593F-4828-AB96-04611E788ABC wds:Q72998755-EA5832FF-6430-4EC9-AA02-6C20D3E83F4F
wdt:P921
wd:Q412323 wd:Q42824440
p:P698
wds:Q72998755-8B744C2C-5DF4-4EB4-B799-74DE6F1802AF
wdtn:P698
n12:12586628
wdt:P698
12586628
p:P1433
wds:Q72998755-AB5E624F-E134-42BB-AE8A-6F0A2CD9AFC6
wdt:P1433
wd:Q885070
p:P433
wds:Q72998755-2F41532C-385C-4235-8986-16C3098CE3C4
p:P478
wds:Q72998755-BBC06F82-90FF-4D30-801D-45AE19545B52
wdt:P433
11
wdt:P478
101
p:P356
wds:Q72998755-D4747DAE-D1E7-4650-8CEE-11D61DBBEB25
wdtn:P356
n8:BLOOD-2002-08-2644
wdt:P356
10.1182/BLOOD-2002-08-2644